Ingmar Bruns
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Ingmar Bruns
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 18 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ingmar Bruns
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ALLAKOS INC. | Pharmaceuticals: Major | Director/Board Member | |
Franklin Templeton Investments Corp.
 Franklin Templeton Investments Corp. Investment ManagersFinance Franklin Templeton Investments Corp. (FTI) is a SEC-registered investment advisor and mutual fund manager headquartered in Toronto, Canada. The firm was founded in 2000 and they are a subsidiary of Templeton International, Inc. Their ultimate parent is Franklin Resources, Inc. (NYSE: BEN), a global investment management company also known as Franklin Templeton Investments. FTI provides investment advisory and portfolio management services with clients in jurisdictions worldwide, which include registered open-end and closed-end funds and unregistered funds, as well as separate accounts for institutional and high net-worth clients. | Investment Managers | Corporate Officer/Principal | |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Founder | |
| London Business School | College/University | Masters Business Admin | |
| CAMBREX CORPORATION | Pharmaceuticals: Generic | Director of Finance/CFO | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Founder | |
| TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Medical/Nursing Services | President | |
| Universität des Saarlandes | College/University | Doctorate Degree | |
PNO Resources Ltd.
 PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | Other Metals/Minerals | Corporate Officer/Principal | |
| AEROCRINE AB | Electronic Equipment/Instruments | Chief Executive Officer | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member | |
| University of Bristol | College/University | Doctorate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| FRANKLIN RESOURCES, INC. | Investment Managers | Corporate Officer/Principal | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Cour Pharmaceuticals Development Co., Inc.
 Cour Pharmaceuticals Development Co., Inc. BiotechnologyHealth Technology Cour Pharmaceuticals Development Co., Inc. engages in the development of therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. Its product pipeline include celiac disease, peanut allergy, multiple sclerosis, and neutralizing antibodies. The company was founded by John J. Puisis and Jim Herrmann and is headquartered in Chicago, IL. | Biotechnology | Chairman | |
| GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
San Diego Athena
 San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| Cyprus Therapeutics, Inc. | Chief Executive Officer | ||
| AVID BIOSERVICES, INC. | Biotechnology | Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | Director/Board Member | |
Infinant Health, Inc.
 Infinant Health, Inc. BiotechnologyHealth Technology Infinant Health, Inc. develops novel solutions to resolve the dysbiosis. It develops a probiotic bacteria activated with specific prebiotic oligosaccharides and delivery systems to provide and maintain a healthy microbiome in infants during the first six months of life. The company is headquartered in Davis, CA. | Biotechnology | Director/Board Member | |
| Rady Children's Institute for Genomic Medicine | Director/Board Member | ||
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| University of California San Diego | College/University | Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Chief Executive Officer | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Doctorate Degree | |
| The University of Queensland | College/University | Doctorate Degree | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 35 |
| Vereinigtes Königreich | 7 |
| Kanada | 6 |
| Schweden | 3 |
| Deutschland | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 10 |
| Finance | 6 |
| Commercial Services | 5 |
| Health Services | 3 |
Operativ
| Director/Board Member | 78 |
| Independent Dir/Board Member | 40 |
| Corporate Officer/Principal | 34 |
| President | 15 |
| Chairman | 14 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Catherine Mackey | 24 |
| Luke Beshar | 19 |
| Scott Myers | 18 |
| Paolo Pucci | 15 |
| Michael Kamarck | 15 |
| James Parsons | 10 |
| Thomas Reynolds | 10 |
| Jan Skvarka | 10 |
| Robert L. Kirkman | 9 |
| Deborah Baron | 9 |
| Paul Walker | 9 |
| Helena Tayton-Martin | 8 |
| Benjamin Looker | 7 |
| Yaping Shou | 5 |
| Rosemary Harrison | 5 |
- Börse
- Insiders
- Ingmar Bruns
- Unternehmensverbindungen
